Clinical Trial Update: Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

View source ↗

Summary

This clinical trial update reports real-world experience with nemolizumab for moderate-to-severe atopic dermatitis in adolescents and adults. The study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Nemolizumab (nemolizumab)

Snippet

Sponsor: Galderma R&D | Conditions: Atopic Dermatitis | Status: RECRUITING